A paper authored by over 200 members of the International Cancer Genome Consortium describes the beginnings of a Brave New World: a new era of personalized medicine for cancer patients. Formed in 2008, the consortium brings together leading cancer researchers from around the world, working together to catalog the genetic changes of the 50 most common cancers -- 500 genomes from each cancer type -- and make the results freely available on the Internet.